Early and Late Side Effects and Patient Management in I-131 Treatment
Journal Title: Nuclear Medicine Seminars - Year 2021, Vol 7, Issue 1
Abstract
I-131 is the first most experienced theranostic radionuclide that has been used since the early 1940s for the treatment of hyperthyroidism, metastases or ablation of residual thyroid tissue in well-differentiated thyroid cancers. Although generally safe and very well tolerated, radioiodine therapy has some potential side effects classified as early and late complications. Early side effects include nausea, rarely vomiting, oral mucositis, sialadenitis, taste disturbance, gastrointestinal, gonadal and hematopoietic system dysfunction and radiation thyroiditis in the cases with large residual tissue. Late complications include secondary cancers, pulmonary fibrosis, and permanent bone marrow suppression. Early complications are generally due to the radioiodine activity and have transient nature, late complications are due to the cumulative radiation dose and are rare. The aim of this article is to review the potential side effects and complications of I-131 therapy and their clinical management.
Authors and Affiliations
Mehmet Reyhan
Keywords
Related Articles
- EP ID EP693443
- DOI 10.4274/nts.galenos.2021.0009
- Views 104
- Downloads 0
Current Good Manufacturing Practice for Radiopharmaceutical Products (GMPR)
Radiopharmaceutical products are classified as specialty medicinal products containing radionuclides whose half-lives range from a few minutes to several days, and therefore they form the basis of the same regulations as...
Differentiated Thyroid Carcinoma in Pediatric Age Group/Differences in Diagnosis, Therapy and Follow-up
Differentiated thyroid cancer in childhood is rare. Although its clinical course is quite aggressive with higher rates of lymph node and pulmonary metastases as compared to adults, the final outcome tends to be favorable...
F-18 FDG PET/CT Practice Guideline in Oncology
Positron emission tomography (PET) is a tomographic imaging method that shows three-dimensional distribution of radiopharmaceuticals which are labelled with positron emitter radionuclides. Today most widely used PET radi...
Nephrourologic Imaging: Yesterday, Today, Tomorrow
Renal function measurement and renal imaging using radionuclidic methods have a long history. Since 1950s, estimation of glomerular function and tubular function were possible using several radiopharmaceuticals. Later, s...
The Role of Nuclear Medicine in Pediatric Hydronephrosis
Nuclear medicine studies are non-invasive, simple, functional diagnostic investigations that can be used in all ages of childhood even in the neonatal period. While dynamic renal scintigraphy has been a well-established...